The University Hospital Foundation was pleased to take the Canadian stage at BIO this afternoon to announce a significant public-private partnership investment in Alberta. (all pictured at left)
Boehringer Ingelheim (Canada) Ltd, Novo Nordisk Canada, and Takeda Canada, are each making a philanthropic investment in the University Hospital Foundation based in Edmonton. The province wide projects totalling $8 million will be investigating Chronic Obstructive Pulmonary Disease, diabetes, and health data analysis.
The Nordisk projects being funded are being led by:
- Dr. Diana Mager - Development of innovative home-based strategies for frailty prevention in the community in adults with Diabetes and Chronic Kidney Disease.
- Dr. Denise Campbell-Scherer - Addressing clinical and social determinants of health to advance obesity and diabetes prevention and management in vulnerable newcomer ethno-cultural communities
- Dr. Padma Kaul - Examining social and clinical determinants of childhood obesity at the population level
Christy Holtby Vice President of Strategic Partnerships for the University Hospital Foundation in Edmonton and Adam Marsella, Novo Nordisk Canada’s Associate Director of External Affairs sat down with me for a few minutes to talk about the new funding.